Bristol Myers Squibb partners with Microsoft on AI lung cancer detection

Go back to Bristol Myers Squibb partners with Microsoft on AI lung cancer detection

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

January 20, 2026 6:59 AM EST

Joint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsofts suite of radiology solutions

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, BMS), a global leader in oncology, today announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies,... More